跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 568 条关于
“epileptic encephalopathies”
全部
568
临床试验
425
药物
10
机构
1
资讯
132
9个月前
Praxis Precision Medicines Reports Positive EMBOLD Study Results for Relutrigine in Rare Epileptic Encephalopathies
2个月前
Lundbeck Completes Randomization in Landmark DEEp OCEAN Phase III Trial of Bexicaserin for Developmental and Epileptic Encephalopathies
去年
Bexicaserin Shows Sustained Seizure Reduction in Developmental Epileptic Encephalopathies
3个月前
Developmental and Epileptic Encephalopathies Market Poised for 11.7% CAGR Growth Through 2036, Driven by Next-Generation Gene and Targeted Therapies
去年
Longboard Pharmaceuticals Launches Phase 3 Trial of Bexicaserin for Developmental and Epileptic Encephalopathies
去年
Longboard Pharmaceuticals Initiates Phase III Trial of Bexicaserin for Developmental and Epileptic Encephalopathies
去年
Lundbeck Presents Bexicaserin Data for Developmental and Epileptic Encephalopathies at AES Annual Meeting
3个月前
DEE Market to Surge Almost 12% Annually on Gene Therapy Advances
9个月前
Praxis Precision Medicines Advances Two CNS Programs with Positive FDA Meeting and Phase 2 Results
去年
UCB Presents Comprehensive Epilepsy Research Portfolio at International Epilepsy Congress 2025
第 1 页,共 14 页
上一页
下一页